Unitree Robotics officially went public today, with its intraday market cap briefly surging past 400 billion yuan!
As the first publicly listed humanoid robotics company, Unitree is certainly attracting plenty of attention. But if we set the emotions aside, its financials and industry competition also deserve a calm look.
For full-year 2025, revenue was 1.7 billion yuan, up approximately 300% year over year; non-GAAP net profit was 591 million yuan, and gross margin for its core business reached as high as 60.13%.
But by the first quarter of 2026, the picture began to change:
Revenue was 423 million yuan, up 68.49% year over year, which was still impressive; however, non-GAAP net profit was only 40.25 million yuan, down 52.55% year over year.
In other words, revenue is still growing rapidly, but the profit side is already facing significant pressure.
More importantly, humanoid robots are still in the stage of ongoing commercial validation. There is still uncertainty over whether real orders can continue and whether large-scale applications can truly be implemented in the future.
At the same time, Tesla, traditional automakers, consumer electronics giants, and a host of robotics startups are all accelerating their entry into the sector.
The hotter the track becomes, the fiercer the competition will be. Future technological iterations, price wars, and declining profit margins could all become challenges Unitree needs to face.
Judging from the current negative funding rates in the derivatives market, market sentiment is actually not as optimistic as one might imagine.
So when looking at Unitree now, two sentiments may coexist:
On the one hand, there is extreme optimism about the future of humanoid robots; on the other, there are concerns about the current valuation and the sustainability of its profitability.
But that has not dampened everyone’s enthusiasm for subscribing to the IPO today😂
One winning allocation is 500 shares. At an offering price of 150.8 yuan per share, the cost per allocation is approximately 75,400 yuan.
If calculated at the intraday price of 884 yuan per share, the unrealized gain on one allocation would reach more than 360,000 yuan.
It has to be said that this kind of money-making effect makes it difficult not to be tempted.
But IPO subscription is one thing, and valuation is another.
In the short term, sentiment matters; over the long term, it still comes down to orders, technology, and genuine commercialization.
As the first publicly listed humanoid robotics company, Unitree is certainly attracting plenty of attention. But if we set the emotions aside, its financials and industry competition also deserve a calm look.
For full-year 2025, revenue was 1.7 billion yuan, up approximately 300% year over year; non-GAAP net profit was 591 million yuan, and gross margin for its core business reached as high as 60.13%.
But by the first quarter of 2026, the picture began to change:
Revenue was 423 million yuan, up 68.49% year over year, which was still impressive; however, non-GAAP net profit was only 40.25 million yuan, down 52.55% year over year.
In other words, revenue is still growing rapidly, but the profit side is already facing significant pressure.
More importantly, humanoid robots are still in the stage of ongoing commercial validation. There is still uncertainty over whether real orders can continue and whether large-scale applications can truly be implemented in the future.
At the same time, Tesla, traditional automakers, consumer electronics giants, and a host of robotics startups are all accelerating their entry into the sector.
The hotter the track becomes, the fiercer the competition will be. Future technological iterations, price wars, and declining profit margins could all become challenges Unitree needs to face.
Judging from the current negative funding rates in the derivatives market, market sentiment is actually not as optimistic as one might imagine.
So when looking at Unitree now, two sentiments may coexist:
On the one hand, there is extreme optimism about the future of humanoid robots; on the other, there are concerns about the current valuation and the sustainability of its profitability.
But that has not dampened everyone’s enthusiasm for subscribing to the IPO today😂
One winning allocation is 500 shares. At an offering price of 150.8 yuan per share, the cost per allocation is approximately 75,400 yuan.
If calculated at the intraday price of 884 yuan per share, the unrealized gain on one allocation would reach more than 360,000 yuan.
It has to be said that this kind of money-making effect makes it difficult not to be tempted.
But IPO subscription is one thing, and valuation is another.
In the short term, sentiment matters; over the long term, it still comes down to orders, technology, and genuine commercialization.
0